Recurrent pleural effusions and cardiac tamponade as possible manifestations of pseudoprogression associated with nivolumab therapy– a report of two cases

Por Kolla, Bhaskar C., Patel, Manish R.
Publicado no J Immunother Cancer (2016)

Endometrial Metastasis of Lung Adenocarcinoma: A Report of Two Cases

Por Ahmad, Zeeshan, Raza, Ahmad, Patel, Manish R.
Publicado no Am J Case Rep (2015)

Resistance to EGFR-TKI can be mediated through multiple signaling pathways converging upon cap-dependent translation in EGFR-wild type NSCLC

Por Patel, Manish R., Jay-Dixon, Joe, Sadiq, Ahad A., Jacobson, Blake A., Kratzke, Robert A.
Publicado em 2013

Noninvasive Imaging of Therapeutic Gene Expression Using a Bi-directional Transcriptional Amplification Strategy

Por Ray, Sunetra, Ramasamy, Paulmurugan, Patel, Manish R, Ahn, Byeong Cheol, Wu, Lily, Carey, Michael, Gambhir, Sanjiv S.
Publicado em 2008

Anti-proliferative effects of Simocyclinone D8 (SD8), a novel catalytic inhibitor of Topoisomerase II

Por Sadiq, Ahad A., Patel, Manish R., Jacobson, Blake A., Escobedo, Marco, Ellis, Keith, Oppegard, Lisa M., Hiasa, Hiroshi, Kratzke, Robert A.
Publicado no Invest New Drugs (2009)

Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation

Por Patel, MANISH R., Sadiq, Ahad A., Jay-Dixon, Joe, Jirakulaporn, Tanawat, Jacobson, Blake A., Farassati, Faris, Bitterman, Peter B., Kratzke, Robert A.
Publicado no Int J Oncol (2011)

Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors

Por Bendell, Johanna C., Patel, Manish R., Yoshida, Kenichiro, Seraj, Jabed, Weaver, Racquel, Lemech, Charlotte, Todaro, Thomas G., Pant, Shubham, Arkenau, Hendrik-Tobias
Publicado no Cancer Chemother Pharmacol (2016)

Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer

Por Bendell, Johanna C., Rosen, Lee S., Mayer, Robert J., Goldman, Jonathan W., Infante, Jeffrey R., Benedetti, Fabio, Lin, Donghu, Mizuguchi, Hirokazu, Zergebel, Christopher, Patel, Manish R.
Publicado no Cancer Chemother Pharmacol (2015)

Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer

Por Bendell, Johanna C., Rosen, Lee S., Mayer, Robert J., Goldman, Jonathan W., Infante, Jeffrey R., Benedetti, Fabio, Lin, Donghu, Mizuguchi, Hirokazu, Zergebel, Christopher, Patel, Manish R.
Publicado no Cancer Chemother Pharmacol (2015)

Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer

Por Chuong, Michael D., Hayman, Tom J., Patel, Manish R., Russell, Mark S., Malafa, Mokenge P., Hodul, Pamela J., Springett, Gregory M., Choi, Junsung, Shridhar, Ravi, Hoffe, Sarah E.
Publicado em 2011

Phase 1, Open-Label, Dose Escalation, Safety, and Pharmacokinetics Study of ME-344 as a Single Agent in Patients With Refractory Solid Tumors

Por Bendell, Johanna C, Patel, Manish R, Infante, Jeffrey R, Kurkjian, Carla D, Jones, Suzanne F, Pant, Shubham, Burris, Howard A, Moreno, Ofir, Esquibel, Vanessa, Levin, Wendy, Moore, Kathleen N
Publicado no Cancer (2015)

Targeting Eukaryotic Translation in Mesothelioma Cells with an eIF4E-Specific Antisense Oligonucleotide

Por Jacobson, Blake A., Thumma, Saritha C., Jay-Dixon, Joseph, Patel, Manish R., Dubear Kroening, K., Kratzke, Marian G., Etchison, Ryan G., Konicek, Bruce W., Graff, Jeremy R., Kratzke, Robert A.
Publicado em 2013

Measles vaccine strains for virotherapy of non-small cell lung carcinoma

Por Patel, Manish R., Jacobson, Blake A., Belgum, Holly, Raza, Ahmad, Sadiq, Ahad, Drees, Jeremy, Wang, Hengbing, Jay-Dixon, Joseph, Etchison, Ryan, Federspiel, Mark J., Russell, Stephen J., Kratzke, Robert A.
Publicado em 2014

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells

Por Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin, M Sondel, Paul, Wakelee, Heather, Disis, Mary L, Creekmore, Stephen P, Miller, Jeffrey S
Publicado no J Immunother Cancer (2014)

Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer

Por Patel, Manish R., Jacobson, Blake A., Ji, Yan, Drees, Jeremy, Tang, Shaogeng, Xiong, Kerry, Wang, Hengbing, Prigge, Jennifer E., Dash, Alexander S., Kratzke, Andrea K., Mesev, Emily, Etchison, Ryan, Federspiel, Mark J., Russell, Stephen J., Kratzke, Robert A.
Publicado no Oncotarget (2015)

Triptolide and its prodrug minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma

Por Jacobson, Blake A., Chen, Esther Z., Tang, Shaogeng, Belgum, Holly Sedgwick, McCauley, Joel A., Evenson, Kristen A., Etchison, Ryan G., Jay-Dixon, Joe, Patel, Manish R., Raza, Ahmad, Saluja, Ashok K., D'Cunha, Jonathan, Kratzke, Robert A.
Publicado no Genes Cancer (2015)

CD8+ T cell stimulation with pegylated recombinant human IL-10 in the patient with advanced solid tumors - a Phase I study

Por Naing, Aung, Infante, Jeffrey R, Papadopoulos, Kyriakos P, Autio, Karen A, Wong, Deborah J, Falchook, Gerald S, Patel, Manish R, Pant, Shubham, Whiteside, Melinda, Bendell, Johanna, Bauer, Todd M, Janku, Filip, Javle, Milind, Colen, Rivka, Tannir, Nizar, Oft, Martin
Publicado no J Immunother Cancer (2015)

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells

Por Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook E, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin C, Sondel, Paul M, Wakelee, Heather A, Apodaca, Minjun C, Fling, Steven P, Disis, Mary L, Creekmore, Stephen P, Miller, Jeffrey S
Publicado no J Immunother Cancer (2015)